590371-71-4 Usage
Uses
Used in Pharmaceutical Industry:
3-IODO-2-(TRIFLUOROMETHYL)PYRIDINE is used as an intermediate in the synthesis of pharmaceuticals for its ability to enhance the properties of target compounds. Its electron-withdrawing nature and the reactivity of the iodo substituent make it a valuable component in the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
3-IODO-2-(TRIFLUOROMETHYL)PYRIDINE is utilized as a building block in the creation of agrochemicals, where its strong electron-withdrawing properties can contribute to the effectiveness of pesticides and other agricultural chemicals. 3-IODO-2-(TRIFLUOROMETHYL)PYRIDINE aids in the design of molecules with increased stability and bioactivity, which is crucial for the development of more efficient and environmentally friendly agrochemicals.
Used in Organic Synthesis:
3-IODO-2-(TRIFLUOROMETHYL)PYRIDINE is employed as a versatile building block in organic synthesis, where its unique structural features allow for the preparation of a wide range of organic compounds. 3-IODO-2-(TRIFLUOROMETHYL)PYRIDINE's reactivity and electron-withdrawing properties make it suitable for various synthetic routes, leading to the creation of novel molecules with potential applications in different fields.
Check Digit Verification of cas no
The CAS Registry Mumber 590371-71-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,9,0,3,7 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 590371-71:
(8*5)+(7*9)+(6*0)+(5*3)+(4*7)+(3*1)+(2*7)+(1*1)=164
164 % 10 = 4
So 590371-71-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H3F3IN/c7-6(8,9)5-4(10)2-1-3-11-5/h1-3H
590371-71-4Relevant articles and documents
HETEROBICYCLIC METALLOPROTEASE INHIBITORS
-
Page/Page column 157, (2008/06/13)
The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.
Recommendable routes to trifluoromethyl-substituted pyridine- and quinolinecarboxylic acids
Cottet, Fabrice,Marull, Marc,Lefebvre, Olivier,Schlosser, Manfred
, p. 1559 - 1568 (2007/10/03)
As part of a case study, rational strategies for the preparation of all ten 2-, 3-, or 4-pyridinecarboxylic acids and all nine 2-, 3-, 4-, or 8-quinolinecarboxylic acids bearing trifluoromethyl substituents at the 2-, 3-, or 4-position were elaborated. The trifluoromethyl group, if not already present in the precursor, was introduced either by the deoxygenative fluorination of suitable carboxylic acids with sulfur tetrafluoride or by the displacement of ring-bound bromine or iodine by trifluoromethylcopper generated in situ. The carboxy function was produced by treatment of organolithium or organomagnesium intermediates, products of halogen/metal or hydrogen/ metal permutation, with carbon dioxide. ( Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003).